| Rene Krupa, RPH | |
|
1329 S Yale Ave, Arlington Heights, IL 60005-3418 | |
| (847) 577-6784 | |
| Not Available |
| Full Name | Rene Krupa |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1329 S Yale Ave, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073865416 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 051.031047 (Illinois) | Primary |
| 183500000X | Pharmacist | PST.019634 (Louisiana) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Rene Krupa, RPH 1329 S Yale Ave, Arlington Heights, IL 60005-3418 Ph: (847) 577-6784 | Rene Krupa, RPH 1329 S Yale Ave, Arlington Heights, IL 60005-3418 Ph: (847) 577-6784 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
In the run up to November's midterm elections, President Obama will tout the new health law, hoping the consumer-friendly provisions taking effect this week will help erode ill will toward the overhaul, The Wall Street Journal reports. "Starting Thursday, insurers officially must adhere to about a half-dozen key changes under the law, including eliminating co-payments for preventive services and allowing children to stay on their parents' insurance policy until their 26th birthday.
A large study of testicular cancer patients has shown that radiation therapy is a better treatment than chemotherapy for patients with stage IIa disease (where one or more regional lymph nodes contain cancer cells but they are less than 2cms in diameter).
The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.
› Verified 6 days ago
George V Cheriyan, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 235 East Palatine Road, Walgreens, Arlington Heights, IL 60004 Phone: 847-394-2420 Fax: 847-394-2339 | |
Mrs. Archana Prashant Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 442 E Rand Rd, Arlington Heights, IL 60004 Phone: 847-255-8754 | |
Dr. Kishan Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 E Golf Rd, Arlington Heights, IL 60005 Phone: 847-593-6650 Fax: 847-593-1856 | |
James Borovilos, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3137 N Wilshire Ln, Arlington Heights, IL 60004 Phone: 847-571-1423 | |
Michelle Tulej, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Northwest Hwy, Arlington Heights, IL 60004 Phone: 847-259-4646 | |
Dr. Nancy Jarsania, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2630 S Embers Ln, Arlington Heights, IL 60005 Phone: 847-640-1318 |